The Role of an EsoDuo® to Control Reflux Symptoms Related to the Acid; a Multicenter, Open-labeled, Phase 4 Study [RACER Study]
Status: Recruiting
Location: See location...
Intervention Type: Drug
Study Type: Interventional
Study Phase: Phase 4
SUMMARY
Clinical Trial to Evaluate the Effects of EsoDuo® in Controlling Reflux Symptoms Related to the Acid
Eligibility
Participation Requirements
Sex: All
Minimum Age: 19
Healthy Volunteers: f
View:
• Male or Female aged ≥ 19 years
• Patients diagnosed with non-erosive reflux disease or mild erosive reflux disease
• Episode of heartburn the GERD symptom(either heartburn or gastric acid reflux)
Locations
Other Locations
Republic of Korea
Asan Medical Center
RECRUITING
Seoul
Contact Information
Primary
Hwoon-Yong Jung, M.D, PhD
hwoonymd@gmail.com
82+2-3010-3197
Time Frame
Start Date: 2022-11-25
Estimated Completion Date: 2025-05
Participants
Target number of participants: 180
Treatments
Experimental: Experimental Group
Related Therapeutic Areas
Sponsors
Leads: Chong Kun Dang Pharmaceutical